<DOC>
	<DOCNO>NCT02310724</DOCNO>
	<brief_summary>The primary objective T2P2 track progression T2D related comorbidities complication TODAY cohort transition young adulthood . We hypothesize : - Youth-onset type 2 diabetes ( T2D ) progress rapidly result high rate diabetes-related medical complication comorbidities . - The rapid rate progression relate increased insulin resistance characteristic puberty , bad Î²-cell function , degree glycemic control , control non-glycemic factor , obesity .</brief_summary>
	<brief_title>TODAY2 Phase 2 Follow-up</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Participated TODAY clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>youth onset type 2 diabetes</keyword>
	<keyword>insulin sensitivity</keyword>
	<keyword>beta cell function</keyword>
	<keyword>macrovascular comorbidities</keyword>
	<keyword>microvascular comorbidities</keyword>
</DOC>